The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Self-citationControlled drug delivery with nanoparticles : current possibilities and future trends
Couvreur, P., Dubernet, C., & Puisieux, F. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 356
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Self-citationPeptide Drug Delivery to the Brain
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-783_2 · Cited by 308
Nerurkar, M. M., Burton, P. S., & Borchardt, R. T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016033702220 · Cited by 287
Reversal of multidrug resistance by surfactants
Woodcock, D., Linsenmeyer, M., Chojnowski, G., Kriegler, A., Nink, V, Webster, L., & Sawyer, W. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.217 · Cited by 233
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
Self-citationToxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded Nanoparticles
Couvreur, P., Kante, B., Grislain, L., Roland, M., & Speiser, P. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710717 · Cited by 217
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Self-citationTröster, S. D., Müller, U., & Kreuter, J. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90047-8 · Cited by 161
Self-citationKattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Alyautdin, R. N., Gothier, D., Петров, Kharkevich, D. A., & Kreuter, J. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 148
Self-citationLiposome targeting to mouse brain: Mannose as a recognition marker
Umezawa, F., & Yoshikatsu, E. T. O. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81333-0 · Cited by 139
Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. P., & Couvreur, P. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897257 · Cited by 130
Borchard, G., Audus, K. L., Shi, F., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90372-7 · Cited by 105
Self-citationDrug Delivery to the Brain by Blood-Brain Barrier Circumvention and Drug Modification
Greig, N. H. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0701-3_12 · Cited by 83
Recent Developments in Peptide Drug Delivery to the Brain
Pardridge, W. M. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb00512.x · Cited by 65
Kreuter, J. (1983) · PubMed · Cited by 60
Self-citationKakinuma, K., Tanaka, R., Takahashi, H. E., Watanabe, M., Nakagawa, T., & Kuroki, M. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.84.2.0180 · Cited by 48
Neuwelt, E. A., Barnett, P. A., Hellström, K. E., Hellström, I., McCormick, C. I., & Ramsey, F. L. (1994) · PubMed · Cited by 43
Begley, D. J. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)62331-6 · Cited by 28
Bigon, E., Boarato, E., Bruni, A., Leon, A. A. G., & Toffano, G. (1979) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1979.tb13661.x · Cited by 28
Cited by
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Metadata
- Authors
- Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J.
- Venue
- Pharmaceutical Research
- Published
- 1999-10
- Volume
- 16
- Issue
- 10
- Pages
- 1564-1569
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1482904772
- Cited by
- 521
- References
- 24
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.